These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. European exploitation of biotechnology-do government policies help? A recent survey of public spending on biotechnology in Europe suggests that money alone cannot stimulate growth of the sector. Senker J; Enzing C; Joly PB; Reiss T Nat Biotechnol; 2000 Jun; 18(6):605-8. PubMed ID: 10835596 [No Abstract] [Full Text] [Related]
5. Basic and applied research in India: present and future. Ramasami T; Rao AV; Natesh S Biotechnol J; 2009 Mar; 4(3):301-5. PubMed ID: 19296436 [No Abstract] [Full Text] [Related]
7. Japanese council urges reform of funding system. Triendl R Nat Biotechnol; 2002 Dec; 20(12):1176-8. PubMed ID: 12454656 [No Abstract] [Full Text] [Related]
8. China moves to reform biotech policies. Jia H Nat Biotechnol; 2004 Oct; 22(10):1197. PubMed ID: 15470442 [No Abstract] [Full Text] [Related]
9. Biotech under Barack. Fox JL Nat Biotechnol; 2009 Mar; 27(3):237-44. PubMed ID: 19270669 [No Abstract] [Full Text] [Related]
10. Plan for $100m boost to Israeli biotech comes under threat. Watzman H Nature; 1998 Mar; 392(6672):117. PubMed ID: 9515950 [No Abstract] [Full Text] [Related]
11. New law to boost French biotech industry. Louët S Nat Biotechnol; 1999 Nov; 17(11):1055. PubMed ID: 10545900 [No Abstract] [Full Text] [Related]
13. The promise of South African biotech. Akermann B; Kermani F Drug Discov Today; 2006 Nov; 11(21-22):962-5. PubMed ID: 17055404 [No Abstract] [Full Text] [Related]
14. Biotechnology gets big backing in Australia. Radke S Nature; 2001 Aug; 412(6849):765. PubMed ID: 11518938 [No Abstract] [Full Text] [Related]
15. Policy. Science policy in Kazakhstan. Schweitzer GE Science; 2008 Dec; 322(5907):1474-5. PubMed ID: 19056962 [No Abstract] [Full Text] [Related]
16. The 20-year African biotech plan. Singh JA; Daar AS Nat Biotechnol; 2008 Mar; 26(3):272-4. PubMed ID: 18327231 [No Abstract] [Full Text] [Related]
17. We speak for small biotech. Vanhemelrijck J Nat Biotechnol; 2008 Jan; 26(1):27-8. PubMed ID: 18183008 [No Abstract] [Full Text] [Related]
18. We speak for small biotech. Sherwin SA Nat Biotechnol; 2008 Jan; 26(1):27. PubMed ID: 18183009 [No Abstract] [Full Text] [Related]
19. Maximizing state and federal spending while minimizing conflicts. Billingsley ML; Washko M Nat Biotechnol; 2006 Dec; 24(12):1473-4. PubMed ID: 17160036 [No Abstract] [Full Text] [Related]
20. The development of China's medical biotech industry needs to be driven by innovation. Yu Z; Dai Y Biotechnol J; 2006 Nov; 1(11):1253-7. PubMed ID: 17068752 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]